Protective Effect of EECP Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 400 participants.
Also called NCT06728605
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 400 participants
- Registry
-
NCT06728605
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06728605. Randomized; quadruple masking; primary purpose prevention. Start 2025-12-31 (anticipated); primary completion 2025-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Protective Effect of EECP Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery
- Acronym
- PANDA
- Condition
- Coronary Heart Disease (CHD)
- Condition
- Cardio-pulmonary Bypass
- Condition
- Congestive Heart Failure Chronic
- Condition
- Cardiogenic Shock Acute
- Intervention (Device)
- Enhanced External Counterpulsation (EECP)
- Intervention (Device)
- Sham Comparator
- Lead sponsor
- Nanjing Medical University
- Collaborator
- The First Affiliated Hospital with Nanjing Medical University
Record details
- Record id
cardio:ct-nct06728605- Content hash
83db27047bd58b65717583b82b8d394d834ba18614c7e2ce3c7892aa8b714f3c